Report Detail

Request for Sample of this report

Pharma & Healthcare Global Microbiome Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4527744
    • |
  • 12 April, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Microbiome Drug is a kind of medicine made with microorganisms. According to the source, it is divided into three categories: drugs derived from whole or part of microorganisms, drugs derived from microbial primary metabolites, and drugs derived from microbial secondary metabolites.
According to our (Global Info Research) latest study, the global Microbiome Drugs market size was valued at USD 228.4 million in 2022 and is forecast to a readjusted size of USD 1691.5 million by 2029 with a CAGR of 33.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America and Europe hold most of market share of microbiome drugs, and North America occupies a share over 77%, on the other hand, Europe takes a share of over 22% in total. Global core microbiome drugs manufacturers include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics etc.
This report is a detailed and comprehensive analysis for global Microbiome Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Symptom. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Microbiome Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Microbiome Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Microbiome Drugs market size and forecasts, by Type and by Symptom, in consumption value ($ Million), 2018-2029
Global Microbiome Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbiome Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbiome Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Microbiome Drugs market is split by Type and by Symptom. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Symptom. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Dosage Form
Enteric Capsules
Market segment by Symptom
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Market segment by players, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microbiome Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microbiome Drugs, with revenue, gross margin and global market share of Microbiome Drugs from 2018 to 2023.
Chapter 3, the Microbiome Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Microbiome Drugs market forecast, by regions, type and symptom, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome Drugs.
Chapter 13, to describe Microbiome Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Microbiome Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Microbiome Drugs by Type
    • 1.3.1 Overview: Global Microbiome Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Microbiome Drugs Consumption Value Market Share by Type in 2022
    • 1.3.3 Oral Dosage Form
    • 1.3.4 Enteric Capsules
  • 1.4 Global Microbiome Drugs Market by Symptom
    • 1.4.1 Overview: Global Microbiome Drugs Market Size by Symptom: 2018 Versus 2022 Versus 2029
    • 1.4.2 Gastrointestinal Disorders
    • 1.4.3 Autoimmune Disorders
    • 1.4.4 Diabetes
    • 1.4.5 Cancer
    • 1.4.6 Others
  • 1.5 Global Microbiome Drugs Market Size & Forecast
  • 1.6 Global Microbiome Drugs Market Size and Forecast by Region
    • 1.6.1 Global Microbiome Drugs Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Microbiome Drugs Market Size by Region, (2018-2029)
    • 1.6.3 North America Microbiome Drugs Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Microbiome Drugs Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Microbiome Drugs Market Size and Prospect (2018-2029)
    • 1.6.6 South America Microbiome Drugs Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Microbiome Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Seres Therapeutics
    • 2.1.1 Seres Therapeutics Details
    • 2.1.2 Seres Therapeutics Major Business
    • 2.1.3 Seres Therapeutics Microbiome Drugs Product and Solutions
    • 2.1.4 Seres Therapeutics Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Seres Therapeutics Recent Developments and Future Plans
  • 2.2 Assembly Biosciences
    • 2.2.1 Assembly Biosciences Details
    • 2.2.2 Assembly Biosciences Major Business
    • 2.2.3 Assembly Biosciences Microbiome Drugs Product and Solutions
    • 2.2.4 Assembly Biosciences Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Assembly Biosciences Recent Developments and Future Plans
  • 2.3 Synthetic Biologics
    • 2.3.1 Synthetic Biologics Details
    • 2.3.2 Synthetic Biologics Major Business
    • 2.3.3 Synthetic Biologics Microbiome Drugs Product and Solutions
    • 2.3.4 Synthetic Biologics Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Synthetic Biologics Recent Developments and Future Plans
  • 2.4 Interxon
    • 2.4.1 Interxon Details
    • 2.4.2 Interxon Major Business
    • 2.4.3 Interxon Microbiome Drugs Product and Solutions
    • 2.4.4 Interxon Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Interxon Recent Developments and Future Plans
  • 2.5 PureTech
    • 2.5.1 PureTech Details
    • 2.5.2 PureTech Major Business
    • 2.5.3 PureTech Microbiome Drugs Product and Solutions
    • 2.5.4 PureTech Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 PureTech Recent Developments and Future Plans
  • 2.6 Synlogic
    • 2.6.1 Synlogic Details
    • 2.6.2 Synlogic Major Business
    • 2.6.3 Synlogic Microbiome Drugs Product and Solutions
    • 2.6.4 Synlogic Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Synlogic Recent Developments and Future Plans
  • 2.7 Enterome BioScience
    • 2.7.1 Enterome BioScience Details
    • 2.7.2 Enterome BioScience Major Business
    • 2.7.3 Enterome BioScience Microbiome Drugs Product and Solutions
    • 2.7.4 Enterome BioScience Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Enterome BioScience Recent Developments and Future Plans
  • 2.8 4D Pharma
    • 2.8.1 4D Pharma Details
    • 2.8.2 4D Pharma Major Business
    • 2.8.3 4D Pharma Microbiome Drugs Product and Solutions
    • 2.8.4 4D Pharma Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 4D Pharma Recent Developments and Future Plans
  • 2.9 Second Genome
    • 2.9.1 Second Genome Details
    • 2.9.2 Second Genome Major Business
    • 2.9.3 Second Genome Microbiome Drugs Product and Solutions
    • 2.9.4 Second Genome Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Second Genome Recent Developments and Future Plans
  • 2.10 AOBiome
    • 2.10.1 AOBiome Details
    • 2.10.2 AOBiome Major Business
    • 2.10.3 AOBiome Microbiome Drugs Product and Solutions
    • 2.10.4 AOBiome Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 AOBiome Recent Developments and Future Plans
  • 2.11 Rebiotix
    • 2.11.1 Rebiotix Details
    • 2.11.2 Rebiotix Major Business
    • 2.11.3 Rebiotix Microbiome Drugs Product and Solutions
    • 2.11.4 Rebiotix Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Rebiotix Recent Developments and Future Plans
  • 2.12 Metabiomics
    • 2.12.1 Metabiomics Details
    • 2.12.2 Metabiomics Major Business
    • 2.12.3 Metabiomics Microbiome Drugs Product and Solutions
    • 2.12.4 Metabiomics Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Metabiomics Recent Developments and Future Plans
  • 2.13 Ritter Pharmaceuticals
    • 2.13.1 Ritter Pharmaceuticals Details
    • 2.13.2 Ritter Pharmaceuticals Major Business
    • 2.13.3 Ritter Pharmaceuticals Microbiome Drugs Product and Solutions
    • 2.13.4 Ritter Pharmaceuticals Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Ritter Pharmaceuticals Recent Developments and Future Plans
  • 2.14 Symberix
    • 2.14.1 Symberix Details
    • 2.14.2 Symberix Major Business
    • 2.14.3 Symberix Microbiome Drugs Product and Solutions
    • 2.14.4 Symberix Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Symberix Recent Developments and Future Plans
  • 2.15 OpenBiome
    • 2.15.1 OpenBiome Details
    • 2.15.2 OpenBiome Major Business
    • 2.15.3 OpenBiome Microbiome Drugs Product and Solutions
    • 2.15.4 OpenBiome Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 OpenBiome Recent Developments and Future Plans
  • 2.16 Azitra
    • 2.16.1 Azitra Details
    • 2.16.2 Azitra Major Business
    • 2.16.3 Azitra Microbiome Drugs Product and Solutions
    • 2.16.4 Azitra Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Azitra Recent Developments and Future Plans
  • 2.17 Osel
    • 2.17.1 Osel Details
    • 2.17.2 Osel Major Business
    • 2.17.3 Osel Microbiome Drugs Product and Solutions
    • 2.17.4 Osel Microbiome Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Osel Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Microbiome Drugs Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Microbiome Drugs by Company Revenue
    • 3.2.2 Top 3 Microbiome Drugs Players Market Share in 2022
    • 3.2.3 Top 6 Microbiome Drugs Players Market Share in 2022
  • 3.3 Microbiome Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Microbiome Drugs Market: Region Footprint
    • 3.3.2 Microbiome Drugs Market: Company Product Type Footprint
    • 3.3.3 Microbiome Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Microbiome Drugs Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Microbiome Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Symptom

  • 5.1 Global Microbiome Drugs Consumption Value Market Share by Symptom (2018-2023)
  • 5.2 Global Microbiome Drugs Market Forecast by Symptom (2024-2029)

6 North America

  • 6.1 North America Microbiome Drugs Consumption Value by Type (2018-2029)
  • 6.2 North America Microbiome Drugs Consumption Value by Symptom (2018-2029)
  • 6.3 North America Microbiome Drugs Market Size by Country
    • 6.3.1 North America Microbiome Drugs Consumption Value by Country (2018-2029)
    • 6.3.2 United States Microbiome Drugs Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Microbiome Drugs Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Microbiome Drugs Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Microbiome Drugs Consumption Value by Type (2018-2029)
  • 7.2 Europe Microbiome Drugs Consumption Value by Symptom (2018-2029)
  • 7.3 Europe Microbiome Drugs Market Size by Country
    • 7.3.1 Europe Microbiome Drugs Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Microbiome Drugs Market Size and Forecast (2018-2029)
    • 7.3.3 France Microbiome Drugs Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Microbiome Drugs Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Microbiome Drugs Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Microbiome Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Microbiome Drugs Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Microbiome Drugs Consumption Value by Symptom (2018-2029)
  • 8.3 Asia-Pacific Microbiome Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Microbiome Drugs Consumption Value by Region (2018-2029)
    • 8.3.2 China Microbiome Drugs Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Microbiome Drugs Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Microbiome Drugs Market Size and Forecast (2018-2029)
    • 8.3.5 India Microbiome Drugs Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Microbiome Drugs Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Microbiome Drugs Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Microbiome Drugs Consumption Value by Type (2018-2029)
  • 9.2 South America Microbiome Drugs Consumption Value by Symptom (2018-2029)
  • 9.3 South America Microbiome Drugs Market Size by Country
    • 9.3.1 South America Microbiome Drugs Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Microbiome Drugs Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Microbiome Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Microbiome Drugs Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Microbiome Drugs Consumption Value by Symptom (2018-2029)
  • 10.3 Middle East & Africa Microbiome Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Microbiome Drugs Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Microbiome Drugs Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Microbiome Drugs Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Microbiome Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Microbiome Drugs Market Drivers
  • 11.2 Microbiome Drugs Market Restraints
  • 11.3 Microbiome Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Microbiome Drugs Industry Chain
  • 12.2 Microbiome Drugs Upstream Analysis
  • 12.3 Microbiome Drugs Midstream Analysis
  • 12.4 Microbiome Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Microbiome Drugs. Industry analysis & Market Report on Microbiome Drugs is a syndicated market report, published as Global Microbiome Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Microbiome Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,752.68
    		4,129.02
    		5,505.36
    		3,208.56
    		4,812.84
    		6,417.12
    		540,444.00
    		810,666.00
    		1,080,888.00
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo